Free tool
FAERS Monitor: Activella
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 022001 or its brand name (Activella, Estradiol, Norethindrone Acetate). Reports on generic versions are filed under their own applications.
Reports
1,888
Serious
1,434
76% of reports
Hospitalization
391
Death reported
37
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- breast cancer282
- breast cancer female191
- fatigue96
- nausea94
- headache80
- dizziness75
- pain69
- drug ineffective68
- off label use64
- feeling abnormal60
- arthralgia58
- diarrhoea56
- anxiety53
- hot flush51
- depression48
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 27 |
| 2005 | 69 |
| 2006 | 81 |
| 2007 | 155 |
| 2008 | 62 |
| 2009 | 151 |
| 2010 | 158 |
| 2011 | 42 |
| 2012 | 38 |
| 2013 | 45 |
| 2014 | 35 |
| 2015 | 63 |
| 2016 | 64 |
| 2017 | 40 |
| 2018 | 56 |
| 2019 | 64 |
| 2020 | 103 |
| 2021 | 90 |
| 2022 | 104 |
| 2023 | 119 |
| 2024 | 106 |
| 2025 | 119 |
| 2026 | 97 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,271 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| breast cancer femaleSignal | 191 | 80.2 | 70.1 | 14,776 |
| breast cancerSignal | 282 | 33.8 | 30.4 | 8,958 |
| hot flushSignal | 51 | 7.5 | 5.8 | 284 |
| feeling abnormalSignal | 60 | 2.8 | 2.2 | 68 |
| depressionSignal | 48 | 2.4 | 1.8 | 36 |
| anxietySignal | 53 | 2.1 | 1.6 | 29 |
| dizziness | 75 | 1.7 | 1.3 | 20 |
| arthralgia | 58 | 1.6 | 1.2 | 11 |
| headache | 80 | 1.4 | 1.1 | 10 |
| fatigue | 96 | 1.4 | 1.1 | 10 |
| nausea | 94 | 1.3 | 1.1 | 7 |
| pain | 69 | 1.3 | 1.0 | 3 |
| diarrhoea | 56 | 1.0 | 0.7 | 0 |
| off label use | 64 | 0.8 | 0.6 | 3 |
| drug ineffective | 68 | 0.6 | 0.5 | 22 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.